http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-33922-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8549fa7263afbaa4fe006643da0d5748 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
| filingDate | 1968-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1974-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-33922-B1 |
| titleOfInvention | Improvements in and relating to vaccines |
| abstract | 1,258,977. Staphylococcal vaccine. CAMELOT DRUG CO. Ltd. 1 July, 1969 [3 July, 1968], No. 33289/69. Heading A5B. A vaccine for the treatment of acne and like conditions comprises an injectable adjuvant containing from in excess of 1000 million to not more than 300,000 million dead staphylococcus aureus organisms per ml. such preparations may be obtained by centrifuging preparations containing lesser concentrations of the organism, e.g. a suspension in physiological saline. The vaccine preferably comprises the organisms adsorbed on aluminium hydroxide gel, aluminium phosphate or aluminium stearate.n[GB1258977A] |
| priorityDate | 1968-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 16.